This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $2,264.76 and a period of performance through April 24, 2025. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUVIA 50 MG TABLET 90S, a medication used to treat diabetes. The contract has a total ceiling value of $6,181.67 and an ultimate completion date of July 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,652.56 and is a firm fixed-price delivery order contract. It does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The award has a ceiling value of $1,229.21 and a period of performance through April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The award has a ceiling value of $1,091.46 and a completion date of May 6, 2025. This contract is not set-aside and is a firm fixed-price, delivery order type. Amerisourcebergen Drug Corp is the prime contractor and holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,638.20 contract is for the delivery of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has a completion date of June 17, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a diabetes medication, with a ceiling value of $16,506.33 and a performance period through June 17, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $3,276.78 and a period of performance through June 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,442.27 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price, with a ceiling value of $1,311.54, and a period of performance ending on April 14, 2025. This contract is not associated with a set-aside program and is an open...